R. Loch Macdonald

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)

R. Loch Macdonald, Randall T. Higashida, E. Keller et al. · The Lancet Neurology · 2011 · 625 citations

Placebo-controlled Phase 3, Endovascular Technique, Vascular Surgery +5

Randomized Trial of Clazosentan in Patients With Aneurysmal Subarachnoid Hemorrhage Undergoing Endovascular Coiling

R. Loch Macdonald, Randall T. Higashida, E. Keller et al. · Stroke · 2012 · 323 citations · Full text

Multilevel anterior cervical corpectomy and fibular allograft fusion for cervical myelopathy

R. Loch Macdonald, Michael G. Fehlings, Charles H. Tator et al. · Journal of neurosurgery · 1997 · 276 citations

Spinal Cord Injury, Multilevel Anterior Decompression, Medicine +12

Development and validation of outcome prediction models for aneurysmal subarachnoid haemorrhage: the SAHIT multinational cohort study

Blessing N. R. Jaja, Gustavo Saposnik, Hester F. Lingsma et al. · BMJ · 2018 · 262 citations · Full text

The critical care management of poor-grade subarachnoid haemorrhage

Airton Leonardo de Oliveira Manoel, Alberto Goffi, Tom Marotta et al. · Critical Care · 2016 · 174 citations · Full text

Neurovascular Disease, Complex Systemic Complications, Management Strategies +16